INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 30, 2003 |
Director
Trans History: 742
|
Director | Form 5 | Bona fide gift | 5,956 | $15.07 | 278,958 |
| Dec 22, 2003 |
Director
Trans History: 312
|
Director | Form 5 | Bona fide gift | 1,000 | -- | 26,975 |
| Dec 22, 2003 |
Director
Trans History: 312
|
Director | Form 5 | Bona fide gift | 1,000 | -- | 25,975 |
| Dec 22, 2003 |
Director
Trans History: 312
|
Director | Form 5 | Bona fide gift | 1,000 | -- | 24,975 |
| Dec 22, 2003 |
Director
Trans History: 312
|
Director | Form 5 | Bona fide gift | 1,000 | -- | 23,975 |
| Aug 20, 2021 |
SVP Controller
Trans History: 306
|
SVP Controller | Form 4/A | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 8,719 | $664.85 | 19,020 |
| May 06, 2013 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4/A | Open market or private sale of non-derivative or derivative security | 12,018 | $263.15 | 114,750 |
| Dec 14, 2010 |
SVP F&A, CFO, Treas & Asst Sec
Trans History: 645
|
SVP F&A, CFO, Treas & Asst Sec | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 73,734 |
| Dec 14, 2010 |
SVP Res and Dev Sciences
Trans History: 660
|
SVP Res and Dev Sciences | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 50,000 | -- | 50,350 |
| Dec 14, 2010 |
Director, EVP CSO & Pres Regn Res Labs
Trans History: 628
|
Director, EVP CSO & Pres Regn Res Labs | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 250,000 | -- | 870,375 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.